Suppr超能文献

轮状病毒肠毒素 NSP4 具有黏膜佐剂特性。

Rotavirus enterotoxin NSP4 has mucosal adjuvant properties.

机构信息

Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

出版信息

Vaccine. 2010 Apr 19;28(18):3106-11. doi: 10.1016/j.vaccine.2010.02.063. Epub 2010 Mar 1.

Abstract

Rotavirus nonstructural protein 4 (NSP4) is a protein with pleiotropic properties. It functions in rotavirus morphogenesis, pathogenesis, and is the first described viral enterotoxin. Since many bacterial toxins function as potent mucosal adjuvants, we evaluated whether baculovirus-expressed recombinant simian rotavirus SA11 NSP4 possesses adjuvant activity by co-administering NSP4 with keyhole limpet hemocyanin (KLH), tetanus toxoid (TT) or ovalbumin (OVA) as model antigens in mice. Following intranasal immunization, NSP4 significantly enhanced both systemic and mucosal immune responses to model immunogens, as compared to the control group, in an antigen-specific manner. Both full-length and a cleavage product of SA11 NSP4 had adjuvant activity, localizing this activity to the C-terminus of the protein. NSP4 forms from virulent and avirulent porcine rotavirus OSU strain, and SA11 NSP4 localized within a 2/6-virus-like particle (VLP) also exhibited adjuvant effects. These studies suggest that the rotavirus enterotoxin NSP4 can function as an adjuvant to enhance immune responses for a co-administered antigen.

摘要

轮状病毒非结构蛋白 4(NSP4)是一种具有多种特性的蛋白质。它在轮状病毒形态发生和发病机制中起作用,是第一个被描述的病毒肠毒素。由于许多细菌毒素作为有效的黏膜佐剂发挥作用,我们评估了杆状病毒表达的重组猿猴轮状病毒 SA11 NSP4 是否具有佐剂活性,方法是将 NSP4 与钥孔血蓝蛋白(KLH)、破伤风类毒素(TT)或卵清蛋白(OVA)共同给药作为模型抗原在小鼠中。与对照组相比,鼻内免疫后,NSP4 以抗原特异性方式显著增强了模型免疫原的全身和黏膜免疫反应。全长和 SA11 NSP4 的一个裂解产物均具有佐剂活性,将这种活性定位于该蛋白的 C 末端。NSP4 由毒力和非毒力猪轮状病毒 OSU 株形成,并且定位于 2/6 病毒样颗粒(VLP)内的 SA11 NSP4 也表现出佐剂效应。这些研究表明,轮状病毒肠毒素 NSP4 可以作为佐剂增强共给药抗原的免疫反应。

相似文献

1
Rotavirus enterotoxin NSP4 has mucosal adjuvant properties.
Vaccine. 2010 Apr 19;28(18):3106-11. doi: 10.1016/j.vaccine.2010.02.063. Epub 2010 Mar 1.
2
Immunization of Mice by Rotavirus NSP4-VP6 Fusion Protein Elicited Stronger Responses Compared to VP6 Alone.
Viral Immunol. 2018 Apr;31(3):233-241. doi: 10.1089/vim.2017.0075. Epub 2017 Nov 29.
3
Mucosal immunization with a ricin toxin B subunit-rotavirus NSP4 fusion protein stimulates a Th1 lymphocyte response.
J Biotechnol. 2006 Jan 24;121(2):272-83. doi: 10.1016/j.jbiotec.2005.07.024. Epub 2005 Sep 21.
5
The synergy of recombinant NSP4 and VP4 from porcine rotavirus elicited a strong mucosal response.
Virology. 2024 Sep;597:110130. doi: 10.1016/j.virol.2024.110130. Epub 2024 Jun 4.
6
A functional NSP4 enterotoxin peptide secreted from rotavirus-infected cells.
J Virol. 2000 Dec;74(24):11663-70. doi: 10.1128/jvi.74.24.11663-11670.2000.
7
Expression and purification of polyhistidine-tagged rotavirus NSP4 proteins in insect cells.
Protein Expr Purif. 2003 Oct;31(2):207-12. doi: 10.1016/s1046-5928(03)00166-9.
8
Humoral immune response to rotavirus NSP4 enterotoxin in Spanish children.
J Med Virol. 2005 Oct;77(2):317-22. doi: 10.1002/jmv.20450.
9
Diarrhea induction by rotavirus NSP4 in the homologous mouse model system.
Virology. 1999 Sep 30;262(2):398-407. doi: 10.1006/viro.1999.9912.

引用本文的文献

3
Effects of rotavirus NSP4 protein on the immune response and protection of the S-VP8* nanoparticle rotavirus vaccine.
Vaccine. 2021 Jan 8;39(2):263-271. doi: 10.1016/j.vaccine.2020.12.005. Epub 2020 Dec 11.
4
Rotavirus vaccine efficacy: current status and areas for improvement.
Hum Vaccin Immunother. 2019;15(6):1237-1250. doi: 10.1080/21645515.2018.1520583. Epub 2018 Sep 19.
5
Analysis of NSP4 Gene and Its Association with Genotyping of Rotavirus Group A in Stool Samples.
Iran Biomed J. 2018 Jan 1;22(1):42-9. doi: 10.22034/ibj.22.1.42. Epub 2017 Jul 11.
8
Rotavirus NSP4 Triggers Secretion of Proinflammatory Cytokines from Macrophages via Toll-Like Receptor 2.
J Virol. 2013 Oct;87(20):11160-7. doi: 10.1128/JVI.03099-12. Epub 2013 Aug 7.

本文引用的文献

1
Virus-like particle vaccines and adjuvants: the HPV paradigm.
Expert Rev Vaccines. 2009 Oct;8(10):1379-98. doi: 10.1586/erv.09.81.
2
Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses.
Ther Clin Risk Manag. 2009 Feb;5(1):125-32. doi: 10.2147/tcrm.s3297. Epub 2009 Mar 26.
3
Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines.
Vaccine. 2008 Aug 19;26 Suppl 10:K62-7. doi: 10.1016/j.vaccine.2008.05.066.
4
Integrins alpha1beta1 and alpha2beta1 are receptors for the rotavirus enterotoxin.
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):8811-8. doi: 10.1073/pnas.0803934105. Epub 2008 Jun 27.
5
Induction of cell signaling events by the cholera toxin B subunit in antigen-presenting cells.
Infect Immun. 2007 Jun;75(6):3150-9. doi: 10.1128/IAI.00581-06. Epub 2007 Mar 12.
7
Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy.
N Engl J Med. 2004 Feb 26;350(9):860-1. doi: 10.1056/NEJMp048006.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验